Acadia Healthcare Company Inc (ACHC) Receives $43.42 Average Target Price from Analysts

Shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) have been given a consensus recommendation of “Hold” by the twelve analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and four have given a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $43.11.

A number of analysts recently issued reports on ACHC shares. BidaskClub lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Thursday, September 13th. ValuEngine lowered Acadia Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, September 6th. Mizuho set a $37.00 price target on Acadia Healthcare and gave the company a “hold” rating in a report on Tuesday, August 28th. Craig Hallum lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, October 17th. They noted that the move was a valuation call. Finally, Cantor Fitzgerald reiterated a “hold” rating and issued a $39.00 price target on shares of Acadia Healthcare in a report on Thursday, October 18th.

A number of institutional investors have recently bought and sold shares of the business. Wells Fargo & Company MN lifted its holdings in shares of Acadia Healthcare by 52.4% during the 1st quarter. Wells Fargo & Company MN now owns 34,769 shares of the company’s stock valued at $1,362,000 after purchasing an additional 11,951 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Acadia Healthcare by 2.8% during the 1st quarter. Principal Financial Group Inc. now owns 356,158 shares of the company’s stock valued at $13,954,000 after purchasing an additional 9,548 shares during the last quarter. UBS Group AG lifted its holdings in shares of Acadia Healthcare by 88.6% during the 1st quarter. UBS Group AG now owns 76,738 shares of the company’s stock valued at $3,007,000 after purchasing an additional 36,045 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of Acadia Healthcare during the 1st quarter valued at $255,000. Finally, Legal & General Group Plc lifted its holdings in shares of Acadia Healthcare by 20.9% during the 1st quarter. Legal & General Group Plc now owns 93,441 shares of the company’s stock valued at $3,661,000 after purchasing an additional 16,126 shares during the last quarter.



Shares of ACHC traded up $0.92 during mid-day trading on Tuesday, reaching $39.50. 2,905,140 shares of the company’s stock traded hands, compared to its average volume of 2,791,010. The stock has a market cap of $3.49 billion, a price-to-earnings ratio of 17.17, a P/E/G ratio of 1.42 and a beta of 0.63. Acadia Healthcare has a 12 month low of $26.92 and a 12 month high of $45.02. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.24 and a current ratio of 1.24.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Monday, July 30th. The company reported $0.70 EPS for the quarter, meeting analysts’ consensus estimates of $0.70. The firm had revenue of $765.70 million for the quarter, compared to analysts’ expectations of $767.93 million. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The company’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.66 earnings per share. As a group, analysts predict that Acadia Healthcare will post 2.52 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Featured Article: Marijuana Stocks Investing Considerations

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply